EDAP TMS SA (EDAP)

Currency in USD
3.520
+0.150(+4.45%)
Closed·
3.5600.000(0.00%)
·
EDAP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.3653.570
52 wk Range
1.2105.050
Key Statistics
Prev. Close
3.37
Open
3.365
Day's Range
3.365-3.57
52 wk Range
1.21-5.05
Volume
27.45K
Average Vol. (3m)
59.07K
1-Year Change
168.7023%
Book Value / Share
0.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EDAP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.500
Upside
+56.25%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

EDAP TMS SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing and sales channels, as well as through third-party distributors and agents. The company serves academic, public, and private hospitals as well as urology clinics. EDAP TMS S.A. was incorporated in 1979 and is based in Vaulx-en-Velin, France.

EDAP TMS SA Earnings Call Summary for Q4/2025

  • Q4 2025 revenue fell 7% to EUR 18.9M, though HIFU segment surged 34% YoY to EUR 11.7M driven by Focal One system sales and treatment revenue.
  • Net loss widened to EUR 8.2M from EUR 1.9M in Q4 2024; gross margin reached 42.6% (46.9% normalized) amid strategic non-core business wind-down.
  • FDA cleared new Focal One system; company expanding into endometriosis and BPH indications to diversify revenue streams beyond prostate cancer.
  • Stock rose 3.38% premarket to $4.042 on investor confidence in HIFU technology leadership and robotic focal therapy market expansion strategy.
  • Management cited currency fluctuations and tariffs as key risks; CEO emphasized continued investment in HIFU innovation and international market penetration.
Last Updated: 03/25/2026, 09:19 AM
Read Full Transcript

Compare EDAP to Peers and Sector

Metrics to compare
EDAP
Peers
Sector
Relationship
P/E Ratio
−4.5x−4.1x−0.5x
PEG Ratio
0.110.130.00
Price / Book
6.8x2.2x2.6x
Price / LTM Sales
1.9x2.6x3.2x
Upside (Analyst Target)
13.0%34.5%47.6%
Fair Value Upside
Unlock7.1%6.1%Unlock

Analyst Ratings

1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.500
(+56.25% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy10.00+184.09%14.00MaintainApr 10, 2026
Piper Sandler
Hold2.50-28.98%1.50MaintainJan 20, 2026
Jefferies
Hold2.00-43.18%1.80MaintainNov 06, 2025
H.C. Wainwright
Buy14.00+297.73%19.00MaintainMay 16, 2025
Piper Sandler
Hold---DowngradeMay 15, 2025

Earnings

Latest Release
Mar 25, 2026
EPS / Forecast
-0.22 / -0.12
Revenue / Forecast
18.94M / 17.75M
EPS Revisions
Last 90 days

EDAP Income Statement

People Also Watch

4.580
BOSC
-0.43%
5.330
GHI
+1.72%
3.4700
HTCR
+5.15%
2.510
DAIO
+2.45%
5.91
FORR
+3.32%

FAQ

What Is the EDAP (EDAP) Stock Price Today?

The EDAP stock price today is 3.520 USD.

What Stock Exchange Does EDAP Trade On?

EDAP is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for EDAP?

The stock symbol for EDAP is "EDAP."

What Is the EDAP Market Cap?

As of today, EDAP market cap is 126.310M USD.

What Is EDAP's Earnings Per Share (TTM)?

The EDAP EPS (TTM) is -0.665.

When Is the Next EDAP Earnings Date?

EDAP will release its next earnings report on May 14, 2026.

From a Technical Analysis Perspective, Is EDAP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has EDAP Stock Split?

EDAP has split 0 times.

How Many Employees Does EDAP Have?

EDAP has 310 employees.

What is the current trading status of EDAP (EDAP)?

As of Apr 16, 2026, EDAP (EDAP) is trading at a price of 3.520 USD, with a previous close of 3.370 USD. The stock has fluctuated within a day range of 3.365 USD to 3.570 USD, while its 52-week range spans from 1.210 USD to 5.050 USD.

What Is EDAP (EDAP) Price Target According to Analysts?

The average 12-month price target for EDAP is 5.500 USD, with a high estimate of 10 USD and a low estimate of 2.5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +56.25% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.